Total Payments
$314,300
2024 Payments
$464.84
Companies
45
Transactions
686
Medicare Patients
5,460
Medicare Billing
$936,757
Payment Breakdown by Category
Other$253,663 (80.7%)
Travel$41,090 (13.1%)
Food & Beverage$11,972 (3.8%)
Consulting$7,474 (2.4%)
Education$101.17 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $228,013 | 116 | 72.5% |
| Travel and Lodging | $41,090 | 158 | 13.1% |
| Honoraria | $22,650 | 13 | 7.2% |
| Food and Beverage | $11,972 | 390 | 3.8% |
| Consulting Fee | $7,474 | 3 | 2.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,000 | 1 | 1.0% |
| Education | $101.17 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Depomed, Inc. | $106,836 | 151 | $0 (2017) |
| US WorldMeds, LLC | $88,410 | 145 | $0 (2020) |
| Assertio Therapeutics, Inc. | $50,384 | 83 | $0 (2020) |
| Pernix Therapeutics Holdings, Inc. | $21,904 | 46 | $0 (2018) |
| Flexion Therapeutics, Inc. | $20,631 | 26 | $0 (2020) |
| Purdue Pharma L.P. | $15,027 | 35 | $0 (2018) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $4,120 | 10 | $0 (2020) |
| Collegium Pharmaceutical, Inc. | $2,004 | 36 | $0 (2024) |
| Boston Scientific Corporation | $1,448 | 23 | $0 (2024) |
| Abbott Laboratories | $600.96 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $464.84 | 23 | Collegium Pharmaceutical, Inc. ($146.26) |
| 2023 | $1,342 | 51 | Scilex Pharmaceuticals Inc. ($214.98) |
| 2022 | $616.03 | 32 | Collegium Pharmaceutical, Inc. ($135.24) |
| 2021 | $270.43 | 14 | Amgen Inc. ($57.31) |
| 2020 | $28,888 | 69 | Flexion Therapeutics, Inc. ($17,215) |
| 2019 | $85,225 | 141 | US WorldMeds, LLC ($81,195) |
| 2018 | $71,452 | 141 | Assertio Therapeutics, Inc. ($50,351) |
| 2017 | $126,042 | 215 | Depomed, Inc. ($106,836) |
All Payment Transactions
686 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Pacira Pharmaceuticals Incorporated | Iovera (Device), Zilretta | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: Pain Management | ||||||
| 12/05/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Analgesic | ||||||
| 11/06/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Neuromodulation | ||||||
| 09/24/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.74 | General |
| Category: Opioid Analgesic | ||||||
| 09/10/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Bone Health | ||||||
| 07/22/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $17.03 | General |
| Category: Opioid Analgesic | ||||||
| 06/18/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Analgesic | ||||||
| 06/12/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.54 | General |
| Category: Opioid Analgesic | ||||||
| 06/05/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Bone Health | ||||||
| 05/16/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Analgesic | ||||||
| 05/09/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: General - Pain Management_NMD | ||||||
| 04/26/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Neuromodulation | ||||||
| 04/15/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.55 | General |
| Category: Opioid Analgesic | ||||||
| 04/11/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Analgesic | ||||||
| 04/03/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Neuromodulation | ||||||
| 03/19/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.71 | General |
| Category: Opioid Analgesic | ||||||
| 02/28/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 02/23/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.55 | General |
| Category: Opioid Analgesic | ||||||
| 02/07/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 01/30/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Bone Health | ||||||
| 01/26/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Analgesic | ||||||
| 01/23/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.14 | General |
| Category: Opioid Analgesic | ||||||
| 01/10/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/18/2023 | Azurity Pharmaceuticals, Inc. | Horizant (Drug) | Food and Beverage | Cash or cash equivalent | $16.22 | General |
| Category: Sleep | ||||||
| 12/11/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.16 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,310 | 5,422 | $486,361 | $235,470 |
| 2022 | 24 | 1,239 | 4,423 | $416,563 | $206,256 |
| 2021 | 24 | 1,551 | 5,222 | $538,494 | $274,350 |
| 2020 | 25 | 1,360 | 4,063 | $467,190 | $220,681 |
Total Patients
5,460
Total Services
19,130
Medicare Billing
$936,757
Procedure Codes
98
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 122 | 169 | $102,000 | $42,915 | 42.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 162 | 305 | $52,553 | $30,646 | 58.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 50 | 78 | $54,905 | $28,913 | 52.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 50 | 123 | $35,836 | $25,111 | 70.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 46 | 81 | $41,748 | $16,390 | 39.3% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 24 | 37 | $26,790 | $13,826 | 51.6% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 21 | 60 | $19,260 | $13,054 | 67.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 99 | 144 | $16,848 | $8,753 | 52.0% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 46 | 78 | $20,164 | $8,179 | 40.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $15,105 | $7,593 | 50.3% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 60 | 80 | $16,200 | $7,558 | 46.7% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 22 | 36 | $17,640 | $7,206 | 40.9% |
| 64479 | Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | Office | 2023 | 22 | 27 | $10,584 | $5,916 | 55.9% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 20 | 25 | $10,296 | $4,308 | 41.8% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 28 | 69 | $7,107 | $3,397 | 47.8% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 20 | 32 | $7,854 | $3,240 | 41.3% |
| 64480 | Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, each additional level | Office | 2023 | 21 | 26 | $4,914 | $2,938 | 59.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 21 | $2,310 | $1,223 | 53.0% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 12 | 12 | $1,992 | $1,186 | 59.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 19 | $2,058 | $1,052 | 51.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,914 | $1,024 | 53.5% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 11 | 12 | $1,080 | $504.03 | 46.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 190 | 3,597 | $1,799 | $348.22 | 19.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 12 | 19 | $204.08 | $149.57 | 73.3% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 165 | 304 | $15,200 | $36.50 | 0.2% |
About Dr. David Lichten, MD
Dr. David Lichten, MD is a Physical Medicine & Rehabilitation healthcare provider based in Pottstown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1366563744.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lichten, MD has received a total of $314,300 in payments from pharmaceutical and medical device companies, with $464.84 received in 2024. These payments were reported across 686 transactions from 45 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($228,013).
As a Medicare-enrolled provider, Lichten has provided services to 5,460 Medicare beneficiaries, totaling 19,130 services with total Medicare billing of $936,757. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Pottstown, PA
- Active Since 04/03/2007
- Last Updated 03/05/2014
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1366563744
Products in Payments
- Lucemyra/Lofexidine (Drug) $87,767
- Gralise (Drug) $79,715
- Nucynta (Drug) $77,295
- ZOHYDRO ER (Drug) $21,904
- Zilretta (Drug) $20,631
- SYMPROIC (Drug) $14,796
- RELISTOR (Drug) $4,120
- Xtampza ER (Drug) $1,433
- SPECTRA WAVEWRITER (Device) $701.52
- EVENITY (Biological) $447.73
- XTAMPZA (Drug) $396.62
- ZTLido (Drug) $390.79
- mild Device Kit (Device) $308.38
- HYSINGLA ER (Drug) $201.74
- PRECISION (Device) $194.95
- PROCLAIM (Device) $183.77
- WaveWriter Alpha Prime 16 (Device) $180.77
- Belbuca (Drug) $174.45
- DRG IPGs (Device) $171.20
- SPECTRA WAVEWRITER (REFURBISHED) (Device) $168.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Pottstown
Dr. Thomas Haley, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $16,247
Physical Medicine & Rehabilitation $16,247
Gregory Chapis, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $4,878
Physical Medicine & Rehabilitation $4,878
Dr. Stanton Bree, D.o, D.O
Physical Medicine & Rehabilitation
Physical Medicine & Rehabilitation